Michael Kreuter
Universidad Nacional de Colombia
H-index: 64
Latin America-Colombia
Top articles of Michael Kreuter
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline | American Journal of Respiratory and Critical Care Medicine | Ganesh Raghu Martine Remy-Jardin Luca Richeldi Carey C Thomson Yoshikazu Inoue | 2022/5/1 |
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled … | The Lancet Respiratory Medicine | Jürgen Behr Antje Prasse Michael Kreuter Johannes Johow Klaus F Rabe | 2021/5/1 |
Global incidence and prevalence of idiopathic pulmonary fibrosis | Toby M Maher Elisabeth Bendstrup Louis Dron Jonathan Langley Gerald Smith | 2021/12 | |
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities | The lancet Respiratory medicine | Peter M George Paolo Spagnolo Michael Kreuter Goksel Altinisik Martina Bonifazi | 2020/9/1 |
Diagnosis of hypersensitivity pneumonitis in adults: an official ATS/JRS/ALAT clinical practice guideline | American journal of respiratory and critical care medicine | Ganesh Raghu Martine Remy-Jardin Christopher J Ryerson Jeffrey L Myers Michael Kreuter | 2020/8/1 |
Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study | American journal of respiratory and critical care medicine | Thomas M Drake Annemarie B Docherty Ewen M Harrison Jennifer K Quint Huzaifa Adamali | 2020/12/15 |
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised … | The lancet Respiratory medicine | Athol U Wells Kevin R Flaherty Kevin K Brown Yoshikazu Inoue Anand Devaraj | 2020/5/1 |
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements | The Lancet Rheumatology | Anna-Maria Hoffmann-Vold Toby M Maher Edward E Philpot Ali Ashrafzadeh Rafic Barake | 2020/2/1 |
SARS‐CoV‐2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells | The EMBO journal | Soeren Lukassen Robert Lorenz Chua Timo Trefzer Nicolas C Kahn Marc A Schneider | 2020/5/18 |